Delivery Order SPE2DB25D3017-SPE2DB25FVJNY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,380.07 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price contract type. The award was competitively procured with no set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $31,913.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by December 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency has awarded a delivery order valued at $16,013.47 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count). This non-competitive, firm fixed-price delivery order is set to be completed by December 4, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $12,258.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. This non-set-aside award was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical federal vendor for military and veteran healthcare systems....
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $30,399.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $25,897.33. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $10,427.06 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $32,737.72 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under...
- The Defense Logistics Agency has awarded a delivery order valued at $106,058.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-set-aside contract employs firm fixed pricing and was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVJNYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $30,804.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price arrangement. The contract, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Eliquis delivery supports the Defense Health Agency and broader military healthcare programs through the DLA's Medical Supply Chain. This transaction exemplifies the company's role as a prime vendor providing brand-name and generic medications across multiple therapeutic domains. The award reflects the competitive acquisition environment for pharmaceutical products, with AmerisourceBergen's demonstrated capability to meet federal procurement requirements alongside other potential contractors under the DLA's Pharmaceutical Prime Vendor Global Program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.8k | 6/24/25 |